SOPHARMA AD (17/2017) Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00
Report no 17/2017
- 20.04.2017, 17:26
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (16/2017) Sopharma AD acquired 51% of RAP Pharma International
Report no 16/2017- 18.04.2017, 18:19
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (15/2017) Notification
Report no 15/2017- 06.04.2017, 16:07
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (14/2017) Sopharma monthly March 2017
Report no 14/2017- 04.04.2017, 14:07
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (13/2017) ANNUAL AUDITED INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 DECEMBER 2016
Report no 13/2017- 31.03.2017, 15:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (12/2017) Notification for a signed annex to the Contract for transformation through merger - Medica AD
Report no 12/2017- 21.03.2017, 14:09
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (11/2017) Extraordinary General Meeting of the shareholders of Sopharma AD
Report no 11/2017- 17.03.2017, 16:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (10/2017) Notification
Report no 10/2017- 09.03.2017, 14:12
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (9/2017) CORRECTION-Sales revenues for the first two months of 2017
Report no 9/2017- 07.03.2017, 14:54
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (9/2017) Sales revenues for the first two months of 2017
Report no 9/2017- 07.03.2017, 14:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
